Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$3.12 - $7.52 $741,574 - $1.79 Million
-237,684 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$6.26 - $14.42 $1.45 Million - $3.35 Million
-232,099 Reduced 49.41%
237,684 $1.72 Million
Q4 2021

Feb 11, 2022

BUY
$11.35 - $21.18 $34 - $63
3 Added 0.0%
469,783 $6.38 Million
Q3 2021

Nov 12, 2021

BUY
$18.17 - $24.7 $4.61 Million - $6.27 Million
253,872 Added 117.58%
469,780 $9.85 Million
Q2 2021

Aug 13, 2021

BUY
$20.08 - $29.02 $319,272 - $461,418
15,900 Added 7.95%
215,908 $5.17 Million
Q4 2020

Feb 10, 2021

BUY
$26.68 - $38.23 $5.34 Million - $7.65 Million
200,008 New
200,008 $5.97 Million

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $51.1M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.